Spiro Rombotis is President at Cyclacel Pharmaceuticals, Inc. (CYCC). They have made 5 open-market trades across 1 company since 2006, most recently 2006-09-15.
CIK 0001357396
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $14K since 2006, never a sale. Across 5 scored buys the stock is down 8.9% at ninety days, and 9.2 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CYCC | 355,148 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2006-09-18 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -30.8% | -8.9% | -8.9% |
| Alpha | -25.0% | -9.2% | -9.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYCC | BUY | 2006-09-14 | 2006-09-18 | $5.60 | $8K | -30.8% | -8.9% | -8.9% |
| CYCC | BUY | 2006-09-12 | 2006-09-13 | $5.95 | $595 | -30.8% | -8.9% | -8.9% |
| CYCC | BUY | 2006-09-08 | 2006-09-12 | $5.72 | $2K | -30.8% | -8.9% | -8.9% |
| CYCC | BUY | 2006-09-06 | 2006-09-08 | $4.67 | $3K | -30.8% | -8.9% | -8.9% |
| CYCC | BUY | 2006-04-17 | 2006-05-18 | $7.74 | $774 | -30.8% | -8.9% | -8.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.